Community HIV clinicians' perceptions about HIV cure-related research in the Northwestern United States
- PMID: 35904107
- PMCID: PMC9836364
Community HIV clinicians' perceptions about HIV cure-related research in the Northwestern United States
Abstract
Background: Research on stakeholder perspectives of HIV cure research has involved people with HIV (PWH), who generally cite the importance of HIV clinician advice in making decisions about trial participation. However, there has been little exploration of non-researcher community HIV clinician perspectives, which are clearly critical to the success of HIV cure-related research.Objective: We aimed to learn how community HIV clinicians perceive HIV cure research and identify factors that would lead them to support or discourage HIV cure trial participation by their patients.Methods: We recruited a purposive sample of 12 community HIV clinicians in metro-Seattle, WA to participate in structured interviews. We completed 11 interviews via teleconference and received one written response. We used conventional content analysis to analyze the data.Results: Overall, community HIV clinicians were supportive of patient participation in HIV cure trials. Factors affecting support included knowledge of local trials, ease of referral, patient immune function and health stability, study risks and benefits, burden of study requirements, patient characteristics, patient life stability, potential impact on engagement in care, study communication plans, and beliefs that patients should have the autonomy to decide to participate. Participants had concerns about trials requiring treatment delays or interruptions and HIV transmission risk. While their knowledge of the field was limited, they were interested in learning more about open HIV cure trials.Conclusions: It would benefit the HIV cure research community if those leading HIV cure trials make stronger efforts to engage community clinicians who care for PWH, but are not active researchers, early in the trial design process. Such engagement prior to launching HIV cure trials will improve trial designs, leading to better enrollment and retention within these important studies.
Keywords: HIV clinicians; HIV cure; HIV cure-related research; analytical treatment interruptions; community clinicians; cure; socio-behavioral sciences.
Conflict of interest statement
Declaration of Interests
We have no competing interest to declare.
Similar articles
-
Ethical and practical considerations for HIV cure-related research at the end-of-life: a qualitative interview and focus group study in the United States.BMC Med Ethics. 2022 Jan 11;23(1):2. doi: 10.1186/s12910-022-00741-8. BMC Med Ethics. 2022. PMID: 35012544 Free PMC article.
-
'Well, It's the Risk of the Unknown… Right?': A Qualitative Study of Perceived Risks and Benefits of HIV Cure Research in the United States.PLoS One. 2017 Jan 25;12(1):e0170112. doi: 10.1371/journal.pone.0170112. eCollection 2017. PLoS One. 2017. PMID: 28122027 Free PMC article.
-
Behavioral and social science research to support development of educational materials for clinical trials of broadly neutralizing antibodies for HIV treatment and prevention.Clin Trials. 2021 Feb;18(1):17-27. doi: 10.1177/1740774520948042. Epub 2020 Aug 24. Clin Trials. 2021. PMID: 32838558 Free PMC article.
-
Applying the Behavioural and Social Sciences Research (BSSR) Functional Framework to HIV Cure Research.J Int AIDS Soc. 2019 Oct;22(10):e25404. doi: 10.1002/jia2.25404. J Int AIDS Soc. 2019. PMID: 31665568 Free PMC article. Review.
-
Participation in HIV cure-related research: a scoping review of the proxy literature and implications for future research.J Virus Erad. 2015 Oct;1(4):250-256. doi: 10.1016/S2055-6640(20)30928-6. J Virus Erad. 2015. PMID: 26866059 Free PMC article.
Cited by
-
HIV Clinical Providers' Awareness, Attitudes, and Willingness to Support Patient Outreach Efforts for HIV Cure-Directed Research in Philadelphia, United States.Open Forum Infect Dis. 2024 Nov 19;11(12):ofae687. doi: 10.1093/ofid/ofae687. eCollection 2024 Dec. Open Forum Infect Dis. 2024. PMID: 39660018 Free PMC article.
-
The Importance of Social Engagement in the Development of an HIV Cure: A Systematic Review of Stakeholder Perspectives.AIDS Behav. 2023 Nov;27(11):3789-3812. doi: 10.1007/s10461-023-04095-z. Epub 2023 Jun 17. AIDS Behav. 2023. PMID: 37329470 Free PMC article. Review.
-
A partner protection package for HIV cure-related trials involving analytical treatment interruptions.Lancet Infect Dis. 2023 Oct;23(10):e418-e430. doi: 10.1016/S1473-3099(23)00267-0. Epub 2023 Jun 6. Lancet Infect Dis. 2023. PMID: 37295453 Free PMC article. Review.
-
HIV cure: an acceptability scientific agenda.Curr Opin HIV AIDS. 2023 Jan 1;18(1):12-17. doi: 10.1097/COH.0000000000000771. Epub 2022 Nov 9. Curr Opin HIV AIDS. 2023. PMID: 36503877 Free PMC article. Review.
-
"This Is Actually a Really Unique Moment in Time": Navigating Long-Acting HIV Treatment and HIV Cure Research with Analytical Treatment Interruptions-A Qualitative Interview Study in the United States.AIDS Res Hum Retroviruses. 2024 Aug;40(8):455-463. doi: 10.1089/AID.2023.0105. Epub 2024 Mar 27. AIDS Res Hum Retroviruses. 2024. PMID: 38386494 Free PMC article.
References
-
- Bloch M, John M, Smith D, Rasmussen T, Wright E. Managing HIV-Associated Inflammation and Ageing in the Era of Modern ART. HIV Med. 2020;21 Suppl 3: 2–16. - PubMed
-
- AVAC. Global Investment in HIV Cure Research and Development. 2021.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical